Cure | Page 13 of 61 | SpiritIndia.com

Alzheimer’s Disease :: Paving the way toward a vaccine against Alzheimer’s disease

Scientists have provided new details about how proteins used to destroy bacteria and viruses may help treat Alzheimer?s disease. Gunnar K. Gouras, associate professor of neurology and neuroscience at Weill Medical College of Cornell University, New York, and colleagues provide new insights into how these proteins, called antibodies, reduce the main hallmarks of Alzheimer?s disease and raise hopes for a vaccine against the disease.

Stem Cell :: Pre-cancerous blood diseases can be products of their environment

When blood-forming stem cells misbehave, causing pre-cancerous conditions that can sometimes even progress to leukemia, the problem might not always lie with them. Rather, two studies in the June 15 issue of the journal Cell, published by Cell Press, reveal that a bad environment might be to blame.

Ovarian Cancer :: First US Consensus on Ovarian Cancer Symptoms

The National Ovarian Cancer Coalition (NOCC) joins the Gynecologic Cancer Foundation and other national organizations in announcing the first national agreement on ovarian cancer symptoms. Often referred to as the ?silent killer? due to the common belief that there are no warning signs or symptoms, ovarian cancer is the most deadly reproductive cancer.

Gene :: Gene switched off in cancer can be turned on

A gene implicated in the development of cancer cells can be switched on using drugs, report researchers from the University of Michigan Comprehensive Cancer Center. The finding could lead to a new class of targeted cancer therapies with potential to benefit many different cancer types.

Meningitis :: Improved meningitis vaccine for Africa could signal eventual end to deadly scourge

The Meningitis Vaccine Project (MVP) released new data on the performance of a meningitis vaccine in West African children, suggesting that the new vaccine?expected to sell initially for 40 US cents a dose?will be much more effective in protecting African children and their communities than any vaccine currently on the market in the region.

Neurology :: Neuroblastoma expert to discuss research, development of novel treatment options

Nina F. Schor, M.D., Ph.D., chair of the Department of Pediatrics, has spent the past two decades researching neuroblastoma, a cancer that grows from immature nerve cells. She will discuss the status of research and development of novel treatment options for the cancer, the most common solid tumor of childhood, at 4 p.m. Friday in the Case Methods Room (1-9576).

Diabetes :: FDA approves Continuous 7-Day Glucose Monitoring System

The U.S. Food and Drug Administration today approved a device that measures glucose levels continuously for up to seven days in people with diabetes.

Meningitis :: Improved meningitis vaccine for Africa could signal eventual end to to deadly scourge

The Meningitis Vaccine Project today released new data on the performance of a meningitis vaccine in West African children, suggesting that the new vaccine — expected to sell initially for 40 US cents a dose — will be much more effective in protecting African children and their communities than any vaccine currently on the market in the region.

HIV :: Roche recalls HIV drug Viracept due to chemical impurity

Roche, in agreement and cooperation with Health Authorities (EMEA and Swissmedic), recalls in Europe and some other world regions all batches of Viracept powder and tablets. The US, Canada and Japan are not affected by this recall.

Emphysema :: Researchers at Cedars-Sinai Medical Center to study airway bypass treatment for emphysema

Researchers at Cedars-Sinai Medical Center announced today the start of the EASE (Exhale Airway Stents for Emphysema) Trial, an international, multi-center clinical trial to explore an investigational treatment that may offer a new, minimally-invasive option for those suffering with advanced widespread emphysema.